What is Cellana?
Cellana operates at the intersection of biotechnology and sustainable manufacturing, utilizing a sophisticated, science-led platform to convert sunlight and carbon dioxide into high-value products. Following its strategic merger with PhytoSmart, the company has refined its operational focus to include the production of Omega-3 fatty acids and plant-based proteins. This integrated approach allows Cellana to address the burgeoning demand for sustainable pet nutrition while simultaneously laying the groundwork for entry into the human functional food market. The company's patented technology serves as a critical differentiator, enabling the transition from pilot-scale operations to large-scale industrial output, thereby ensuring both environmental sustainability and long-term economic viability.
How much funding has Cellana raised?
Cellana has raised a total of $14M across 2 funding rounds:
Unspecified
$9M
Grant
$5M
Unspecified (2010): $9M, investors not publicly disclosed
Grant (2011): $5M, investors not publicly disclosed
Key Investors in Cellana
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Cellana?
With the recent capital injection, Cellana is poised to accelerate its commercialization roadmap, specifically targeting the expansion of its production capacity to meet the requirements of the pet nutrition industry. The company's strategic trajectory involves a phased rollout of its product portfolio, with a clear objective to penetrate the human nutrition and functional food markets by 2026. By maintaining a focus on operational efficiency and leveraging its extensive data-driven insights, Cellana aims to solidify its position as a leader in the algae-based ingredient space. Future growth will likely be defined by the successful scaling of its photosynthetic platforms and the continued diversification of its industrial applications, ensuring that the firm remains at the forefront of the bio-economy.
See full Cellana company page
